FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013093849> ?p ?o ?g. }

• W2013093849 endingPage "152" @default.
• W2013093849 startingPage "144" @default.
• W2013093849 abstract "TNF-α is a crucial cytokine in the establishment and maintenance of inflammation in multiple autoimmune and non-autoimmune disorders. A number of large placebo-controlled trials have shown that infliximab, a chimeric monoclonal antibody against TNF-α, is effective and well-tolerated in patients with Crohn's disease and rheumatoid arthritis (RA) and has become a widely used treatment for these diseases. More recent controlled trials have also shown the effectiveness of TNF-α blockers in psoriasis, psoriatic arthritis, and ankylosing spondylitis. The results of clinical trials, open-label studies, and case studies indicate that TNF inhibitors (alone or in combination with other protocols) look very promising for the treatment of a variety of other conditions, including uveitis, sarcoidosis, Sjögren's syndrome (SS), Behçet's syndrome, vasculitis, and graft versus host disease. There is a rationale for using TNF blockade even in systemic lupus erythematosus, a prototype of autoantibody-mediated disease, and a pilot study seems to confirm this potential effective approach. The neutralisation of TNF might therefore play a role in the treatment of many autoimmune and non-autoimmune disorders other than Crohn's disease or RA. We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions that do not currently have FDA or EMEA approval." @default.
• W2013093849 created "2016-06-24" @default.
• W2013093849 creator A5010984168 @default.
• W2013093849 creator A5051145762 @default.
• W2013093849 creator A5059300420 @default.
• W2013093849 creator A5074477451 @default.
• W2013093849 creator A5080993054 @default.
• W2013093849 date "2005-03-01" @default.
• W2013093849 modified "2023-10-12" @default.
• W2013093849 title "Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review" @default.
• W2013093849 cites W1480420413 @default.
• W2013093849 cites W1759284956 @default.
• W2013093849 cites W1911529226 @default.
• W2013093849 cites W1927468586 @default.
• W2013093849 cites W1965793179 @default.
• W2013093849 cites W1981494429 @default.
• W2013093849 cites W1985728577 @default.
• W2013093849 cites W1985763670 @default.
• W2013093849 cites W2001288327 @default.
• W2013093849 cites W2006521487 @default.
• W2013093849 cites W2017762949 @default.
• W2013093849 cites W2023772270 @default.
• W2013093849 cites W2031173848 @default.
• W2013093849 cites W2034608764 @default.
• W2013093849 cites W2059189040 @default.
• W2013093849 cites W2071461632 @default.
• W2013093849 cites W2079148993 @default.
• W2013093849 cites W2080147816 @default.
• W2013093849 cites W2085406842 @default.
• W2013093849 cites W2087989258 @default.
• W2013093849 cites W2108529019 @default.
• W2013093849 cites W2110118006 @default.
• W2013093849 cites W2110285242 @default.
• W2013093849 cites W2110706809 @default.
• W2013093849 cites W2111967039 @default.
• W2013093849 cites W2113402062 @default.
• W2013093849 cites W2116078431 @default.
• W2013093849 cites W2129654663 @default.
• W2013093849 cites W2156748803 @default.
• W2013093849 cites W2161446589 @default.
• W2013093849 cites W2164079830 @default.
• W2013093849 cites W2169004170 @default.
• W2013093849 cites W2406608300 @default.
• W2013093849 cites W2440360957 @default.
• W2013093849 cites W96108004 @default.
• W2013093849 doi "https://doi.org/10.1016/j.autrev.2004.08.004" @default.
• W2013093849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15823500" @default.
• W2013093849 hasPublicationYear "2005" @default.
• W2013093849 type Work @default.
• W2013093849 sameAs 2013093849 @default.
• W2013093849 citedByCount "40" @default.
• W2013093849 countsByYear W20130938492013 @default.
• W2013093849 countsByYear W20130938492015 @default.
• W2013093849 countsByYear W20130938492016 @default.
• W2013093849 countsByYear W20130938492017 @default.
• W2013093849 countsByYear W20130938492019 @default.
• W2013093849 countsByYear W20130938492020 @default.
• W2013093849 crossrefType "journal-article" @default.
• W2013093849 hasAuthorship W2013093849A5010984168 @default.
• W2013093849 hasAuthorship W2013093849A5051145762 @default.
• W2013093849 hasAuthorship W2013093849A5059300420 @default.
• W2013093849 hasAuthorship W2013093849A5074477451 @default.
• W2013093849 hasAuthorship W2013093849A5080993054 @default.
• W2013093849 hasConcept C126322002 @default.
• W2013093849 hasConcept C159654299 @default.
• W2013093849 hasConcept C17991360 @default.
• W2013093849 hasConcept C203014093 @default.
• W2013093849 hasConcept C2776194053 @default.
• W2013093849 hasConcept C2776260265 @default.
• W2013093849 hasConcept C2776760755 @default.
• W2013093849 hasConcept C2777077863 @default.
• W2013093849 hasConcept C2777138892 @default.
• W2013093849 hasConcept C2777402515 @default.
• W2013093849 hasConcept C2777575956 @default.
• W2013093849 hasConcept C2779075594 @default.
• W2013093849 hasConcept C2779134260 @default.
• W2013093849 hasConcept C2779280984 @default.
• W2013093849 hasConcept C2780132546 @default.
• W2013093849 hasConcept C2780564577 @default.
• W2013093849 hasConcept C71924100 @default.
• W2013093849 hasConceptScore W2013093849C126322002 @default.
• W2013093849 hasConceptScore W2013093849C159654299 @default.
• W2013093849 hasConceptScore W2013093849C17991360 @default.
• W2013093849 hasConceptScore W2013093849C203014093 @default.
• W2013093849 hasConceptScore W2013093849C2776194053 @default.
• W2013093849 hasConceptScore W2013093849C2776260265 @default.
• W2013093849 hasConceptScore W2013093849C2776760755 @default.
• W2013093849 hasConceptScore W2013093849C2777077863 @default.
• W2013093849 hasConceptScore W2013093849C2777138892 @default.
• W2013093849 hasConceptScore W2013093849C2777402515 @default.
• W2013093849 hasConceptScore W2013093849C2777575956 @default.
• W2013093849 hasConceptScore W2013093849C2779075594 @default.
• W2013093849 hasConceptScore W2013093849C2779134260 @default.
• W2013093849 hasConceptScore W2013093849C2779280984 @default.
• W2013093849 hasConceptScore W2013093849C2780132546 @default.
• W2013093849 hasConceptScore W2013093849C2780564577 @default.
• W2013093849 hasConceptScore W2013093849C71924100 @default.
• W2013093849 hasIssue "3" @default.

• next